Srinivasulu Ganganamoni

Title: Innovations by Srinivasulu Ganganamoni

Introduction

Srinivasulu Ganganamoni is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-proliferative compounds. With a total of 2 patents to his name, his work is recognized for its potential impact on therapeutic treatments.

Latest Patents

Ganganamoni's latest patents include the invention of 1H-1,8-naphthyridin-2-ones as anti-proliferative compounds. This invention relates to novel antiproliferative 1H-1,8-naphthyridin-2-ones of the general formula (I) or pharmaceutically acceptable salts thereof. The variable groups are defined within the patent, and the compounds are prepared for use in therapeutic treatment of disorders related to the inhibition of tyrosine kinases in warm-blooded animals. Notably, these compounds can overcome imatinib-induced drug resistance, showcasing their potential in cancer treatment.

Career Highlights

Srinivasulu Ganganamoni is currently associated with Natco Pharma Limited, where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to developing effective treatments that address critical health challenges.

Collaborations

Ganganamoni collaborates with talented professionals in his field, including Amala Kompella and Venugopala Krishna Gampa. These collaborations enhance the research and development efforts at Natco Pharma Limited.

Conclusion

Srinivasulu Ganganamoni's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work not only advances scientific knowledge but also has the potential to improve therapeutic outcomes for patients.